Back to search
Melasma (Facial Melasma)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Melasma (Facial Melasma) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Melasma (Facial Melasma) trials you may qualify forMelasma is a chronic acquired hyperpigmentation disorder that commonly affects the face and has a significant impact on quality of life. Available treatments ma…
Melasma is a localized, acquired hyperpigmentary skin disorder characterized by well-defined, light to dark brown patches. Based on clinical practice and extens…
The goal of this clinical trial is to compare the dermatological tolerance and skin-lightening efficacy of a cosmetic depigmenting serum to a 4% hydroquinone-ba…
The objective of this study is to evaluate the efficacy, cosmetic acceptability and improvement of the stigmatization of the tested product (2039125 03) used bi…
The objective of this study is to evaluate the efficacy, cosmetic acceptability and improvement of the stigmatization of the tested product (2039125 03) used bi…
study was conducted on middle aged male and female, including families and health care professional also.
It's a prospective, randomised, assessor-blinded clinical study comparing topical 30% metformin with Kligman's regimen for melasma in women aged 35-55 years at…
Melasma is a common skin condition that causes dark patches on the face and can significantly affect quality of life. This study compared two commonly used topi…